These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 25749658)

  • 1. Effects of complementary and integrative medicine on cancer survivorship.
    Frenkel M; Sierpina V; Sapire K
    Curr Oncol Rep; 2015; 17(5):445. PubMed ID: 25749658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer-Related Fatigue-Is There a Role for Complementary and Integrative Medicine?
    David A; Hausner D; Frenkel M
    Curr Oncol Rep; 2021 Nov; 23(12):145. PubMed ID: 34743258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complementary and Integrative Medicine in Pancreatic Cancer.
    Frenkel M; David A; Sapire K; Hausner D
    Curr Oncol Rep; 2023 Mar; 25(3):231-242. PubMed ID: 36735141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effective communication about the use of complementary and integrative medicine in cancer care.
    Frenkel M; Cohen L
    J Altern Complement Med; 2014 Jan; 20(1):12-8. PubMed ID: 23863085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrative Medicine: Adjunctive Element or Essential Ingredient in Palliative and Supportive Cancer Care?
    Frenkel M; Sapire K; Lacey J; Sierpina VS
    J Altern Complement Med; 2020 Sep; 26(9):779-783. PubMed ID: 32924563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of training oncology physicians advising patients on complementary and integrative therapies on patient-reported outcomes: 2-year follow-up of the multi-center, cluster-randomized KOKON-KTO study.
    Rogge AA; Helmer SM; Icke K; Witt CM
    Cancer Med; 2024 Jul; 13(14):e70008. PubMed ID: 39031953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploring an Integrative Patient-Tailored Complementary Medicine Approach for Chemotherapy-Induced Taste Disorders.
    Ben-Arye E; Doweck I; Schiff E; Samuels N
    Explore (NY); 2018; 14(4):289-294. PubMed ID: 29785939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of a complementary/integrative medicine program on the need for supportive cancer care-related medications.
    Shalom-Sharabi I; Samuels N; Lev E; Lavie O; Keinan-Boker L; Schiff E; Ben-Arye E
    Support Care Cancer; 2017 Oct; 25(10):3181-3190. PubMed ID: 28434097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychosocial/survivorship issues in breast cancer: are we doing better?
    Fallowfield L; Jenkins V
    J Natl Cancer Inst; 2015 Jan; 107(1):335. PubMed ID: 25432407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term effectiveness of an E-based survivorship care plan for breast cancer survivors: A quasi-experimental study.
    Fang SY; Wang YL; Lu WH; Lee KT; Kuo YL; Fetzer SJ
    Patient Educ Couns; 2020 Mar; 103(3):549-555. PubMed ID: 31558323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complementary and Integrative Medicine in Hematologic Malignancies: Questions and Challenges.
    Frenkel M; Sapire K
    Curr Oncol Rep; 2017 Oct; 19(12):79. PubMed ID: 29032389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized controlled trial of mindfulness-based stress reduction (MBSR) for survivors of breast cancer.
    Lengacher CA; Johnson-Mallard V; Post-White J; Moscoso MS; Jacobsen PB; Klein TW; Widen RH; Fitzgerald SG; Shelton MM; Barta M; Goodman M; Cox CE; Kip KE
    Psychooncology; 2009 Dec; 18(12):1261-72. PubMed ID: 19235193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fear of cancer recurrence across the survivorship trajectory: Results from a survey of adult long-term cancer survivors.
    Götze H; Taubenheim S; Dietz A; Lordick F; Mehnert-Theuerkauf A
    Psychooncology; 2019 Oct; 28(10):2033-2041. PubMed ID: 31364222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An exploratory typology of provider responses that encourage and discourage conversation about complementary and integrative medicine during routine oncology visits.
    Koenig CJ; Ho EY; Trupin L; Dohan D
    Patient Educ Couns; 2015 Jul; 98(7):857-63. PubMed ID: 25865412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kidney Cancer Integrative Oncology: Possible Options for Care.
    Mathis S; Sierpina VS
    Curr Oncol Rep; 2023 Sep; 25(9):1071-1080. PubMed ID: 37466849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrative oncology: an overview.
    Deng G; Cassileth B
    Am Soc Clin Oncol Educ Book; 2014; ():233-42. PubMed ID: 24857081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of a blended-learning training concept to train oncology physicians to advise their patients about complementary and integrative medicine (KOKON-KTO): study protocol for a prospective, multi-center, cluster-randomized trial.
    Helmer SM; Rogge AA; Fischer F; Pach D; Horneber M; Roll S; Witt CM
    Trials; 2019 Jan; 20(1):90. PubMed ID: 30696465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Attitudes Among Nurses Toward the Integration of Complementary Medicine Into Supportive Cancer Care.
    Ben-Arye E; Shulman B; Eilon Y; Woitiz R; Cherniak V; Shalom Sharabi I; Sher O; Reches H; Katz Y; Arad M; Schiff E; Samuels N; Caspi O; Lev-Ari S; Frenkel M; Agbarya A; Admi H
    Oncol Nurs Forum; 2017 Jul; 44(4):428-434. PubMed ID: 28632238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Training Oncology Physicians to Advise Their Patients on Complementary and Integrative Medicine.
    Witt CM
    J Altern Complement Med; 2018; 24(9-10):1016-1017. PubMed ID: 30247966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Providing integrative care in the pre-chemotherapy setting: a pragmatic controlled patient-centered trial with implications for supportive cancer care.
    Ben-Arye E; Dahly H; Keshet Y; Dagash J; Samuels N
    J Cancer Res Clin Oncol; 2018 Sep; 144(9):1825-1833. PubMed ID: 29980837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.